An Operationally Seamless, Randomized Phase 2/3 Study Consisting of a Phase 2 Single-Blind, Dose-Evaluation Phase and a Phase 3 Double-Blind, Placebo-controlled Phase to Assess the Efficacy and Safety of Setrusumab in Subjects with Osteogenesis Imperfecta
![](https://researchstudies.cuanschutz.edu/Content/images/study-category-images/genetics.jpg)
Description
A clinical trial examining the efficacy of Setrusumab in reducing fractures compared to a placebo for patients with Osteogenesis Imperfecta.
Details
Age
Child to Adult
Eligibility
Diagnosis of Osteogeneis Imperfecta Type 1,3, or 4
Locations
Childrens Hospital Colorado
Principal Investigator
![Photograph of Klane White](https://som.ucdenver.edu/FIMS/Content/faculty/37615/CU-Doctors-37615.jpg)
Klane White
Study ID
Protocol Number: 22-2292
Categories
Is this Study for You?
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers